UK First Varian Halcyon Cancer Treatment Systems Scheduled for Queens Hospital

Cancer patients in the U.K. will gain access to the country first Varian Halcyon radiotherapy treatment devices when the first of two systems are delivered to Queens Hospital near London later this month.

National Cancer Institute designates UCLA brain cancer program a site of research excellence

The brain cancer program at UCLA Jonsson Comprehensive Cancer Center and the UCLA Brain Tumor Center has been designated a Specialized Program of Research Excellence, or SPORE...

Cardiac SPECT solution at the ASNCs Annual Scientific Session launched by Philips

Royal Philips , a global leader in health technology, today announced its presence at the American Society of Nuclear Cardiology Annual Scientific Session in Kansas City, Missouri, from September 14 – 17, 2017.

Top 4 essentials for the providers to ensure their patients are satisfied

Digital transformation and the transition to value based care are pushing care providers to change their patient experience approach. Patients desire the same customization and digital services in healthcare as they receive across retail and other industries

Poliovirus Therapy Induces Immune Responses Against Cancer

An investigational therapy using modified poliovirus to attack cancer tumors appears to unleash the body own capacity to fight malignancies by activating an inflammation process that counter the ability of cancer cells to evade the immune system

Improving the efficiency and safety of regional anaesthesia with point-of-care ultrasound

Ultrasound guidance is proving invaluable for the regional neurosurgical centre at the Salford Royal Hospital, helping to improve safety, save time and enhance the patient experience